...
首页> 外文期刊>Journal of Clinical Microbiology >High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.
【24h】

High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.

机译:用于测定对肠球菌的氨基糖苷-Penicillin协同作用的高含量氨基糖苷圆盘。

获取原文
           

摘要

We investigated the use of high-content aminoglycoside disks for determining Enterococcus faecalis susceptibility to aminoglycoside-penicillin synergy. The susceptibility of the organisms to synergy was established by 24-h time-kill studies performed with streptomycin, kanamycin, amikacin, gentamicin, and tobramycin, alone and in combination with penicillin. A total of 20 isolates that were susceptible to all drug combinations and 20 strains that were resistant to each aminoglycoside-penicillin combination were selected for testing against high-content disks. Disk-agar diffusion was performed on Mueller-Hinton agar, with and without 5% sheep blood, by using disks that contained either 300 or 2,000 micrograms of streptomycin and either 120 or 2,000 micrograms of kanamycin, amikacin, tobramycin, or gentamicin. Zone size results obtained for each aminoglycoside, except amikacin, could be used to differentiate between synergy-susceptible and -resistant isolates. No overlap occurred between the zone sizes of susceptible and resistant strains. Susceptibility to amikacin-penicillin synergy could reliably be tested with kanamycin, but not amikacin, disks. When the disks containing 120 micrograms were tested, a narrow zone size range of 6 to 7 mm could be used to identify all resistant strains. In contrast, when the disks containing 2,000 micrograms were used, the zone size ranges for resistant isolates varied widely with the aminoglycoside being tested. The presence of blood in the medium did not appreciably affect the disk test results. To detect resistance to every aminoglycoside-penicillin combination that may be considered for therapy, E. faecalis isolates need to be tested against a maximum of three different high-content disks (i.e., streptomycin, gentamicin, kanamycin). The disk-agar diffusion test performed with high-content aminoglycoside disks can provide laboratories with a convenient and reliable method for detecting E. faecalis isolates that are resistant to aminoglycoside-penicillin synergy.
机译:我们调查了使用高含量的氨基糖苷盘来确定对氨基糖苷 - 青霉素协同作用的肠球菌粪便易感性。通过用链霉素,卡那霉素,阿米卡星,庆大霉素和青霉素组合进行24-h次杀死生物体对协同作用的敏感性。选择易受所有药物组合的20个分离物和20个抗性对每种氨基糖苷类 - 青霉素组合的20种菌株进行测试,用于测试高含量盘。通过使用含有300或2,000微克链霉素的盘和120或2,000微克的卡那霉素,Amikacin,染发霉素或庆大霉素,在穆勒 - 六冬琼琼脂对穆勒 - 六冬琼琼脂进行,而没有5%绵羊血液进行,用含有300或2,000微克的链霉素血液进行。除了Amikacin之外,每种氨基糖苷的区域尺寸结果可用于区分协同易受敏感和耐药性的分离物。在易感和抗性菌株的区域尺寸之间不会发生重叠。对Amikacin-penicillin协同作用的易感性可靠地用kanamycin测试,但不是Amikacin,磁盘。当测试含有120微克微克的盘时,可用于识别所有抗性菌株的窄区尺寸范围为6至7mm。相反,当使用含有2,000微克的盘时,用于抗性隔离物的区域尺寸范围随着测试的氨基糖苷而广泛变化。培养基中血液的存在并未显着影响磁盘测试结果。为了检测可能考虑治疗的每种氨基糖苷类 - 青霉素组合的抵抗力,E.粪便分离物是针对最多三种不同的高含量盘(即链霉素,庆大霉素,卡那霉素)进行测试。用高含量的氨基糖苷盘进行的盘琼脂扩散试验可以提供实验室,具有方便可靠的方法,用于检测对氨基糖苷-Penicillin协同作用的E.粪便分离物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号